You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Ganga Pharmaceuticals Ltd"

Ganga Pharmaceuticals Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate

  • 01/06/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Submission Of Compliance Certificate Under Regulation 7 (3) Of SEBI(Listing Obligations And Disclosu

  • 29/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Change in Management

  • 25/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Director

  • 23/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2020

  • 13/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 12/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2020

  • 09/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations

  • 09/05/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Closure of Trading Window

  • 31/03/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Resignation of Director

  • 27/02/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2019

  • 21/01/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2019

  • 14/01/2020
  • |
  • bse

Ganga Pharmaceuticals Ltd Submission Of Rectified Statement Of Assets And Liabilities As At September 30 2019

  • 04/12/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Submission Of Rectified Statement Of Assets And Liabilities As At September 30 2019

  • 04/12/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Disclosure Under Reg. 23(9) Of SEBI (LODR) Regulations 2015

  • 20/11/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2019.

  • 14/11/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Considering A

  • 05/11/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Shareholding for the Period Ended September 30 2019

  • 19/10/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 17/10/2019
  • |
  • bse

Ganga Pharmaceuticals Ltd Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations

  • 16/10/2019
  • |
  • bse